As featured in
Follow
Overview
News
Technologies
Salaries
Products
People
Growth
Financials
Overview
Fulcrum is a Ukrainian product studio founded in 2015 and headquartered in Kyiv. It designs and builds digital products for startups and scale-ups. The company covers discovery, design and engineering.
News
Kaplan Fox is Investigating Possible Securities Law Violations Against Fulcrum Therapeutics, Inc. (NASDAQ: FULC)
NEW YORK, NY - August 27, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Fulcrum Therapeutics, Inc. (
Read more
Report
Fulcrum wipes the Slate clean with $245m reverse merger
Fulcrum Therapeutics and Slate Medicines have agreed to combine in a reverse merger, giving the migraine specialist a fast route to the public markets.
Read more
Report
Fulcrum, Slate Medicines sign merger agreement
Fulcrum Therapeutics and Slate Medicines have signed a definitive agreement to merge in an all-stock transaction backed by a $245m private placement financing from a syndicate of healthcare investors.
Read more
Report
Fulcrum Therapeutics to Merge With Slate Medicines in $245 Million Backed Migraine Play
Fulcrum Therapeutics and Slate Medicines announced an all-stock merger on Monday that will create a Nasdaq-listed company focused on migraine…
Read more
Report
After failure in sickle cell, Fulcrum merges with Slate
Following the failure of its sickle cell programme, Fulcrum Therapeutics will merge with Slate Medicines to advance Slate's migraine therapy.
Read more
Report
Pro access
Upgrade to see all 40 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.
